A comparative clinical study to involving Ayurvedic drug intervention in the management of COVID 19 patients.
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- To reduce Virus Clearance Time.
研究概览
简要总结
This was a randomized Clinical comparative study to be conducted at Lokbandhu Rajanarayan Combined Hospital, a COVID 19 level 2 Hospital in Lucknow, Uttar Pradesh. The prime objective was to ascertain the role of Ayurvedic medicine in the Management of COVID 19 Pandemic in India.
Theobservations were noticed and results were analyzed statistically. Improvementin symptoms, enhancement in Agni and recovery from COVID-19 infection was observed. The results obtained were encouraging and showed betterviral clearance and control of symptom progression in the patients placed onAyurvedic medications.
The most significant findingin this study was that a restrain was observed in the disease progression torigorous stages and evasion of population spread due to faster viral clearancein the management of COVID-19 cases with Ayurveda drugs in both groups A and B than the control group.
This paves the way toa more integrated approach towards this pandemic wherein community spread andprogression to severe stages is the key for its restraint. From here a moreholistic and progressively planned study may be considered involving largersample base for the management of the more severe form of the morbidity whichis the current need of the hour to minimize the mortalities worldwide.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 25.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients tested Positive for COVID
- •Asymptomatic Patients or with Mild Symptoms.
- •Those willing to give informed Consent.
排除标准
- •Patients below 25 years and above 60 years of age.
- •Patients presenting with increased severity of disease.
- •Those having serious Comorbidities, including Diabetes, Hypertension.
- •Pregnant Women those not willing to give consent.
结局指标
主要结局
To reduce Virus Clearance Time.
时间窗: 5 days and 10 days
To improve General Quality of Life.
时间窗: 5 days and 10 days
To assess role of Ayurveda medicines in the COVID 19 Pandemic management.
时间窗: 5 days and 10 days
To minimise the chances of Disease progression in terms of Severity.
时间窗: 5 days and 10 days
To establish Ayurvedic drugs role in National programme for COVID management
时间窗: 5 days and 10 days
次要结局
- To ascertain role of Ayurveda in the National management of COVID 19 Pandemic(5 days and 10 days)